Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983 Feb;15(2):211–220. doi: 10.1111/j.1365-2125.1983.tb01488.x

Sulphate conjugation of p-hydroxytriamterene by platelet phenol sulphotransferase: assay conditions and correlation with metabolism in man.

C Reiter, P G Werness, J Van Loon, L H Smith, R M Weinshilboum
PMCID: PMC1427853  PMID: 6573903

Abstract

1 Sulphate conjugation catalyzed by phenol sulphotransferase (PST) is an important pathway in the metabolism of many drugs including triamterene. Variations in PST activity in an easily obtained tissue such as the platelet might reflect individual differences in the sulphate conjugation in other organs and tissues. Human platelets contain at least two forms of PST, a thermolabile (TL) form for which dopamine is a substrate and a thermostable (TS) form for which low concentrations of p-nitrophenol serve as a substrate. 2 p-OH-triamterene, the major metabolite of triamterene, is conjugated with sulphate in vivo. p-OH-triamterene was a substrate for platelet PST with an apparent Michaelis-Menten value of 26 microM. Thermal stability studies indicated that p-OH-triamterene was a substrate for only the TS form of platelet PST. 3 When platelet homogenates from 29 individual subjects were tested, there was a significant correlation between PST activities measured with 4 microM p-nitrophenol and with p-OH-triamterene (r = 0.985, P less than 0.0001) but not between activities measured with dopamine and with p-OH-triamterene (r = 0.023, P greater than 0.2). These results confirmed that p-OH-triamterene was a substrate for only the TS form of human platelet PST. 4 The same 29 subjects were treated with 1 mg/kg of triamterene orally. 24-h urinary excretions of triamterene, p-OH-triamterene and p-OH-triamterene sulphate averaged 15.3%, 6.3% and 78.4%, respectively, of the total of triamterene plus measured metabolites excreted. The excretion of triamterene plus the two metabolites averaged 43.1 +/- 2.6% (mean +/- s.e. mean) of the ingested dose. There was not a significant correlation between the proportion of p-OH-triamterene excreted as sulphate conjugate and the activities of either the TS or TL forms of platelet PST activity.

Full text

PDF
211

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson R. J., Weinshilboum R. M. Phenolsulphotransferase in human tissue: radiochemical enzymatic assay and biochemical properties. Clin Chim Acta. 1980 Apr 11;103(1):79–90. doi: 10.1016/0009-8981(80)90233-8. [DOI] [PubMed] [Google Scholar]
  2. Anderson R. J., Weinshilboum R. M., Phillips S. F., Broughton D. D. Human platelet phenol sulphotransferase: assay procedure, substrate and tissue correlations. Clin Chim Acta. 1981 Mar 5;110(2-3):157–167. doi: 10.1016/0009-8981(81)90345-4. [DOI] [PubMed] [Google Scholar]
  3. Andrasch H., Fink T., Schmid E. Uber die Harnausscheidung des Antikaliuretikums Triamteren und seines phenolischen Metaboliten 2,4,7-Triamino-6-p-hydroxyphenylpteridin bei Lebergesunden und Kranken mit Leberzirrhose. Z Gastroenterol. 1971;9(4):240–245. [PubMed] [Google Scholar]
  4. CLELAND W. W. Computer programmes for processing enzyme kinetic data. Nature. 1963 May 4;198:463–465. doi: 10.1038/198463a0. [DOI] [PubMed] [Google Scholar]
  5. Carter S. M., Glover V., Sandler M., Gillman P. K., Bridges P. K. Human platelet phenolsulphotransferase: separate control of the two forms and activity range in depressive illness. Clin Chim Acta. 1981 Dec 24;117(3):333–344. doi: 10.1016/0009-8981(81)90121-2. [DOI] [PubMed] [Google Scholar]
  6. Ettinger B., Oldroyd N. O., Sörgel F. Triamterene nephrolithiasis. JAMA. 1980 Nov 28;244(21):2443–2445. [PubMed] [Google Scholar]
  7. Ettinger B., Weil E., Mandel N. S., Darling S. Triamterene-induced nephrolithiasis. Ann Intern Med. 1979 Nov;91(5):745–746. doi: 10.7326/0003-4819-91-5-745. [DOI] [PubMed] [Google Scholar]
  8. Foldes A., Meek J. L. Rat brain phenolsulfotransferase: partial purification and some properties. Biochim Biophys Acta. 1973 Dec 19;327(2):365–374. doi: 10.1016/0005-2744(73)90419-1. [DOI] [PubMed] [Google Scholar]
  9. Gundert-Remy U., von Kenne D., Weber E., Geissler H. E., Grebian B., Mutschler E. Plasma and urinary levels of triamterene and certain metabolites after oral administration to man. Eur J Clin Pharmacol. 1979 Aug;16(1):39–44. doi: 10.1007/BF00644964. [DOI] [PubMed] [Google Scholar]
  10. Hart R. F., Renskers K. J., Nelson E. B., Roth J. A. Localization and characterization of phenol sulfotransferase in human platelets. Life Sci. 1979 Jan 8;24(2):125–130. doi: 10.1016/0024-3205(79)90121-8. [DOI] [PubMed] [Google Scholar]
  11. Lehmann K. Trennung, Isolierung und Identifizierung von Stoffwechselprodukten des Triamterens. Arzneimittelforschung. 1965 Jul;15(7):812–816. [PubMed] [Google Scholar]
  12. Lin J. H., Levy G. Effect of experimental renal failure on sulfate retention and acetaminophen pharmacokinetics in rats. J Pharmacol Exp Ther. 1982 Apr;221(1):80–84. [PubMed] [Google Scholar]
  13. Mwaluko G., Weinshilboum R. alpha-Methyldopa, alpha-methyldopamine an alpha-methylnoradrenaline: substrates for the thermolabile form of human platelet phenol sulphotransferase. Br J Clin Pharmacol. 1982 Aug;14(2):231–239. doi: 10.1111/j.1365-2125.1982.tb01967.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Patel K. M. Triamterene nephrolithiasis complicating dyazide therapy. J Urol. 1981 Aug;126(2):230–230. doi: 10.1016/s0022-5347(17)54456-0. [DOI] [PubMed] [Google Scholar]
  15. Reiter C., Weinshilboum R. M. Acetaminophen and phenol: substrates for both a thermostable and a thermolabile form of human platelet phenol sulfotransferase. J Pharmacol Exp Ther. 1982 Apr;221(1):43–51. [PubMed] [Google Scholar]
  16. Reiter C., Weinshilboum R. Platelet phenol sulfotransferase activity: correlation with sulfate conjugation of acetaminophen. Clin Pharmacol Ther. 1982 Nov;32(5):612–621. doi: 10.1038/clpt.1982.211. [DOI] [PubMed] [Google Scholar]
  17. Slattery J. T., Levy G. Acetaminophen kinetics in acutely poisoned patients. Clin Pharmacol Ther. 1979 Feb;25(2):184–195. doi: 10.1002/cpt1979252184. [DOI] [PubMed] [Google Scholar]
  18. WILKINSON G. N. Statistical estimations in enzyme kinetics. Biochem J. 1961 Aug;80:324–332. doi: 10.1042/bj0800324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Werness P. G., Bergert J. H., Smith L. H. Triamterene urolithiasis: solubility, pk, effect on crystal formation, and matrix binding of triamterene and its metabolites. J Lab Clin Med. 1982 Feb;99(2):254–262. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES